Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Individual ingredients have published research, but no OTC finished product has been shown in a peer-reviewed trial to replicate the 7-24% body weight loss that prescription GLP-1 receptor agonists produce
But for many sufferers, the problem stems from an underlying vitamin B12 deficiency
To determine the causal direction and assess the potential therapeutic value of regulating regulation in obesity-related metabolic diseases, further in-depth mechanistic and translational medicine research is needed to clarify the causal relationships and identify potential intervention targets within this endocrine-metabolic network
Stick with it
According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence
Track puncture dates and discard any vial that has been reconstituted for more than 28 days, even if peptide remains
